Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ia/Ib Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Including Patients With TP53 Mutations

NCT06549790 is registered in ClinicalTrials.gov with Nerviano Medical Sciences as lead sponsor.

NCT NCT06549790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06549790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ia/Ib Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Including Patients With TP53 Mutations
Lead sponsor
Nerviano Medical Sciences
Phase
Phase 1
Overall status
Recruiting
Start date
October 16, 2024
Completion date
May 15, 2030
Enrollment
124 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory acute myeloid leukemia